Douglas Carr - SVP Finance & Operations at Century Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP Finance & Operations
Stock Symbol
IPSC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Douglas Carr - trading volume in the past year for Century Therapeutics, Inc.

Holdings reported by Douglas Carr for Century Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 405K $237K $0.59 Nov 3, 2025 Direct
Stock Option (right to buy) 95.6K Mar 11, 2025 Direct Common Stock

Transactions reported by Douglas Carr for Century Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.